KEYNOTE SPEAKERS
Thomas W. Abrams, RPh, MBA
Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Silver Spring, MD
Leslie Backschies, MA
Supervisor Special Agent and Unit Chief, International Corruption Unit, Federal Bureau of Investigation, Los Angeles, CA
Richard Bistrong, MA
Chief Executive Officer, Front-Line Anti-Bribery LLC, Contributing Editor, FCPA Blog, Former Confidential Human Source (CHS) and Cooperating Witness, FBI and US DOJ, Former Cooperating Witness, City of London Police, HMRC and CPS, UK, New York, NY, USA
Hui Chen, JD
Ethics and Compliance Advocate and Consultant, HC Ethics LLC; Former Compliance Counsel Expert (Consultant), US Department of Justice; Former Assistant General Counsel, Pfizer, New York, NY
Zachary A. Cunha, JD
Assistant US Attorney and Chief, Civil Division, US Attorney’s Office, District of Rhode Island, US Department of Justice, Former AUSA, District of Massachusetts and Eastern District of New York, Providence, RI
Susan Dentzer
President and Chief Executive Officer, NEHI, (The Network for Excellence in Health Innovation), Analyst on Health Policy, The NewsHour, Former Editor, Health Affairs, Washington, DC
Jacob Elberg, JD
Assistant US Attorney, US Attorney’s Office, District of New Jersey, US Department of Justice, Newark, NJ
Christopher B. Harwood, JD
Assistant US Attorney and Chief of the Civil Health Care Fraud Unit, US Attorney’s Office, Southern District of New York, Former Assistant US. Attorney, US Attorney’s Office for the District of Columbia, US Department of Justice, New York, NY
Tarek Helou, Esq.
Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC
Rachael Honig, JD
First Assistant US Attorney, US Attorney’s Office for the District of New Jersey, Former Corporate Counsel, Litigation, Celgene, New York, NY
Mary E. Riordan, Esq.
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC
Gregg Shapiro, JD
Assistant US Attorney, US Attorney’s Office, District of Massachusetts, US Department of Justice, Boston, MA
Sally Q. Yates, JD
Partner, King and Spalding, Former Acting Attorney General, Former Deputy Attorney General, Former Assistant US Attorney, US Attorney’s Office, Northern District of Georgia, US Department of Justice, Washington, DC
AGENDA-AT-A-GLANCE
WEDNESDAY, NOVEMBER 7
FEATURING AN INVITATION-ONLY CCO ROUNDTABLE
PRECONFERENCE SESSIONS
OPENING PLENARY SESSION
THURSDAY, NOVEMBER 8
MORNING PLENARY SESSION
MINI SUMMITS
MINI SUMMITS, CONTINUED…
CLOSING PLENARY SESSION
FRIDAY, NOVEMBER 9
INDUSTRY-ONLY BEST PRACTICES ROUNDTABLE
FEATURED SESSION: ANNUAL CCO ROUNDTABLE WITH
Jill Fallows-Macaluso, JD
Chief Compliance Officer and Vice President, Novo-Nordisk, Princeton, NJ
Jonathon Kellerman
Executive Vice President, Global Chief Compliance Officer, Allergan PLC, Former Partner, PwC, Parsippany, NJ
Robert A. Ladd, JD
Vice President, Global Head Integrity & Compliance, Oncology, Novartis; Former, General Counsel, GE Healthcare Partners; East Hanover, NJ
Puja Leekha, JD
Vice President, Chief Compliance Officer and Corporate Counsel, Corporate Compliance, Lundbeck Pharmaceuticals LLC, Former Division Legal Counsel & Compliance Officer, Stryker Corporation, Deerfield, IL
Lori Queisser
Sr VP and Global CCO, Teva, Former Sr. VP Global Compliance & Business Practices, Schering-Plough, Former VP & CCO, Eli Lilly, Former Co-chair, PCF, Horsham, PA
Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory, Deloitte, Atlanta, GA (Moderator)
FEATURED FACULTY
James Accumanno, JD
Director Risk, Monitoring and Auditing, Novo Nordisk, Former Associate Counsel, Bayer, Philadelphia, PA
Anthony Alvizu, CPA, EnCE, CFE
Managing Director, Global Risk & Investigations Practice (GRIP), FTI Consulting, Chicago, IL
Eliza L. Andonova, JD
Counsel, Hogan Lovells, Washington, DC
Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma PLC, Former VP, Chief Compliance Officer, Dendreon, Chicago, IL
Eric Baim, JD
Managing Director, Dovetail Consulting Group, LLC, Former VP, Head of US Compliance, Shire, Boston, MA
Yogesh Bahl, CPA, MBA
Managing Director, Alix Partners, New York, NY
Minna Bak, MBA
Senior Manager, Helio Health Group, New York, NY
Jennifer Barbre, MA
Executive Director, Compliance, Spectrum Pharmaceuticals, Inc., Former Director, Compliance and Ethics Program, Avanir, Irvine, CA
Dennis K. Barnes, JD, MBA, CPA
Vice President, Global Governance, Risk and Compliance, Mayne Pharma, Raleigh-Durham, NC
Scott Bass, JD
Partner and Head, Global Life Sciences Team, Sidley Austin LLP, New York, NY
Ann E. Beasley, JD
Director, Life Sciences, Governance, Risk & Compliance, Navigant, Former Senior Vice President, Chief Compliance Officer, Biogen, Boston, MA
Thomas Beimers, JD
Partner, Hogan Lovells, Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS, Minneapolis, MN and Washington, DC
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP; Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice; Washington, DC
Andrew Blasi
Director, C&M International, Crowell & Moring, Former Pamela Harriman Foreign Service Fellow, US Embassy in London, Former Congressional Liaison, Australian Embassy and Foreign Affairs Subcommittee on Europe, US House of Representatives, Washington, DC
Brian A. Bohnenkamp, MHA, JD
Partner, FDA & Life Sciences Practice, King & Spalding LLP, Washington, DC
Christine N. Bradshaw, JD
Vice President, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ
Julianne Brierley
Director, Head of Compliance Learning, Novartis, New York, NY
Katherine Buckley, MBA
Partner, Pharmaceutical and Life Sciences Advisory Practice, PwC, Philadelphia, PA
Terra Buckley, JD
Executive Director, US HCC Business Advisory Center of Excellence, Celgene, Former Head, US Compliance, Helsinn, Summit, NJ
Ed Buthusiem, JD
Managing Director, Berkeley Research Group, Adjunct Professor Of Law, Temple University, Former SVP, R&D Legal Operations & Vaccines, GSK, Devon, PA
Joseph Calarco
Chief Compliance Officer at Neos Therapeutics, Inc., Philadelphia, PA
Christie Camelio
Vice President and US Healthcare Compliance Officer, Celgene, Former Head of Risk Management, Novartis, Summit, NJ
Regina G. Cavaliere, JD
Principal, Regulatory Enforcement & Compliance, Life Sciences Sector, KPMG LLP, Former VP and CCO, Otsuka America, Short Hills, NJ
Nicole Chandonnet, JD
Associate, Covington & Burling, Washington, DC
Katherine Chaurette, JD
Senior Director, Assistant General Counsel, Regeneron Pharmaceuticals, Inc., Boston, MA
Jennifer Chillas, JD
Senior Corporate Counsel, Bristol-Myers Squibb; Former Associate, Ropes & Gray, LLP; Princeton, NJ
Craig Chiulli, MBA
Group Product Director, Metabolic Franchise, Johnson & Johnson, Titusville, NJ
Craig Clesson, JD, CIPP/US
Assistant General Counsel and Global Privacy Officer, Syneos Health; Former Vice President and Ethics and Compliance Officer, Aegerion; Boston, MA
William Connelly, JD
Senior Counsel, Amgen; Former Staff Attorney, US DHHS, Washington, DC
Brian Conner
Vice President, Head of Corporate Compliance, Strongbridge Biopharma plc, Trevose, PA
Kellie Branson Combs, JD
Counsel, Ropes & Gray LLP, Washington, DC
Thomas Costa, JD
Member, US Board of Directors, Sanofi; Former Vice President, US Compliance & Ethics, Bristol-Myers Squibb, Washington, DC
Clarissa Crain
Senior Manager, Life Sciences Advisory, Deloitte, Philadelphia, PA
Jill Dailey, MBA, JD
Vice President & Chief Compliance Officer, Incyte, Former AG, Asia Pac Lead, Pfizer, Former Head, US Ethics and Compliance, Novartis, New York, NY
Meenakshi Datta, JD
Partner and Global Co-leader, Healthcare Practice, Sidley Austin LLP, Chicago, IL
Mahnu V. Davar, JD
Partner, Arnold & Porter Kaye Scholer LLP, Lecturer, University of Pennsylvania Law School, Fellow, Salzburg Global Seminar, Washington, DC
BJ D’Avella
Senior Manager, Life Sciences Regulatory and Operational Risk, Deloitte & Touche LLP, Atlanta, GA
Sharon R. Delshad, JD
Director, Compliance and Legal Affairs, Nalpropion, Former Director, Compliance and Legal Affairs, Orexigen Therapeutics, San Diego, CA
Gary Del Vecchio
Health Care CO Cardiovascular & Metabolism, Janssen, Former ED US Pharma Compliance & Ethics, Bristol-Myers Squibb, Former PCF Co-chair, New York, NY
Mark A. DeWyngaert, MBA, PhD
Managing Director, Life Sciences Regulatory and Operational Risk, Deloitte & Touche LLP, New York, NY
Sarah diFrancesca, JD
Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY
Christian A. Dingler
Managing Consultant, Navigant Consulting, Richmond, VA
Stefanie A. Doebler, JD
Of Counsel, Covington & Burling LLP, Washington, DC
Suzanne E. Durrell, JD
Managing Member, Whistleblower Law Collaborative, LLC, Taxpayers Against Fraud Education Fund, 2017 Whistleblower Lawyer of the Year, Boston, MA
Michael Dusseau
Vice President, Compliance Operations, Allergan, Former Vice President, Compliance, Bayer, Former Divisional Compliance Officer, Merck, Madison, NJ
Eileen Erdos
Principal, Forensic and Integrity Services, Ernst & Young LLP, Chicago, IL
Melanie Fagan
HCP Engagement Lead, Medical Affairs Compliance, GlaxoSmithKline, Philadelphia, PA
J. Mark Farrar, CPA, CFE, CFF
Managing Director, Navigant; Former Interim Global Chief Compliance Officer, Beckman Coulter, Atlanta, GA, USA
Alison Fethke, JD
Counsel, Ropes & Gray LLP, Former Division Counsel, Legal, Regulatory and Compliance, AbbVie, Chicago, IL
Kellie Fidler, MBA, PMP
Director, Global Compliance Risk Mitigation & Monitoring Strategy, Bristol-Myers Squibb, Princeton Pike, NJ
Francisco Ribeiro Filho, MBA
Senior Director & Head of US Compliance, Tesaro, Inc., Former Sr. Dir., Corporate Compliance, Biogen, Former Sr. Dir., International Markets, Sandoz, Boston, MA
Paul Fishman, JD
Partner and Head, Crisis Management and Strategic Response Team, Arnold & Porter LLP, Former United States Attorney, District of New Jersey, Washington, DC
Paul Flanagan, JD
Assistant Professor of Law, Thomas R. Kline School of Law, Drexel University, Former Chief Compliance and Privacy Officer, 21st Century Oncology, West Chester, PA
Sarah A. Franklin, JD
Partner, Covington & Burling LLP, Former Attorney, Federal Trade Commission, Washington, DC
Charlene Keller Fullmer, JD
Assistant United States Attorney and Deputy Chief, Affirmative Litigation, United States Attorney’s Office, Eastern District of Pennsylvania, Philadelphia, PA
Alex Ganz, JD
Senior Manager of Compliance, Aegerion Pharmaceuticals, Former Compliance Manager, Shire and Vertex, Boston, MA
Nereyda Garcia, JD
Global Heath, Ethics and Compliance, Alnylam Pharmaceuticals, Former Sr. Director, Compliance, Biogen Idec, Cambridge, MA
Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings; Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc.; New York, NY
Virginia “Ginny” A. Gibson, JD
Partner, Hogan Lovells LLP, Former First Assistant U.S. Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA
Jonathan Glazier, JD, MBA
Head, Legal Compliance, Philips, Former Sr. Dir., Corporate Compliance and Privacy Officer, Fresenius, Andover, MA
Wendy C. Goldstein, JD
Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY
Anthony Greco, MBA
Director, Pharmaceutical & Life Sciences Advisory Services, PwC, Philadelphia, PA
Adam Greene, JD, MPH
Partner and Co-chair, Health Information & HIPAA Practice, Davis Wright Tremaine LLP, Former Senior HIT & Privacy Specialist, OCR, DHHS, Washington, DC
Lillian S. Hardy, JD
Partner, Hogan Lovells LLP, Washington, DC
Patricia J. Harned, PhD
Chief Executive Officer, ECI (Ethics and Compliance Initiative), Former President, Ethics Resource Center, Washington, DC
Kate Heinzelman, JD
Counsel, Sidley Austin LLP, Former Deputy GC, US DHHS, Former Special Assistant and Associate Counsel, President Barack Obama, Washington, DC
Laura G. Hoey, JD
Co-leader, Government Enforcement and White Collar Group and Health Care and Life Sciences Industry Group, Ropes & Gray LLP, Chicago, IL
Christine Hood
Director, Learning and Development, Chiesi, Former District Sales Manager, Boehringer Ingelheim, Former Sales Trainer, Biovail, Apex, NC
Casey J. Horton, CFE
Director, Life Sciences, Governance, Risk & Compliance, Navigant, Chicago, IL
Emily Huebener, MA
Forensic and Integrity Services, Ernst & Young LLP, Chicago, IL
Erinn Hutchinson
Partner, Advisory Services, PwC, Philadelphia, PA
Michael Joachim, JD
Global Business Partner, Ethics & Business Integrity, Sanofi Genzyme, Cambridge, MA
Elizabeth Jobes, JD
Head, Corporate Compliance & Legal Counsel, Spark, Former Senior VP & CCO, Auxilium, Former PCF Co-chair, Philadelphia, PA
Darren R. Jones
Partner, Global Compliance Consulting Leader, Polaris Management, New York, NY
Marci Juneau, MBA
Partner, Helio Health Group, Atlanta, GA
Kiley Smith Kelly, MBA
Partner, Forensic and Integrity Services, Ernst & Young LLP, Philadelphia, PA
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC
Daniel A. Kracov, JD
Partner, Arnold & Porter Kaye Scholer LLP, Washington, DC
Daryl Kreml, JD
VP & CCO, Sage, Former Head, US Compliance & Global Program Management, Biogen, Former Dir. & Sen. Managing Counsel, Int’l Compliance, Boston Scientific, Boston, MA
Joseph Lake, MS
Global Healthcare Compliance & Third Party Monitoring Lead, Bristol-Myers Squibb, Former Group Internal Audit, Sanofi, Former Director, Global Compliance Organization, Merck, Morristown, NJ
Bharathram Lakshmivarahan, MBA
Life Sciences Strategy & Operations Consultant, PwC, San Francisco, CA
Marc Levine
Director of Compliance, Insightec, Former Compliance Officer, Stryker Corporation, Former Business Conduct Specialist, MAKO Surgical, Fort Lauderdale, FL
Jonathan Levy, JD
Corporate Compliance Counsel, Spark Therapeutics; Former Associate Director of Compliance and Ethics, US Pharmaceuticals, Bristol-Myers Squibb; Philadelphia, PA
Jodi Lindsey, JD
Senior Director & Head of US Healthcare Compliance, Alkermes, Former Associate Director, Commercial Compliance, Biogen, Boston, MA
Richard Liner, JD
Senior Counsel, Compliance and Investigations, Bayer, Whippany, NJ
Chad Londeree
Healthcare Industry Group Leader, SAI Global, Richmond, VA
Pamela Lonzer, MSJ
Ass. Dir., Medical Operations, Compliance & Controls, Alexion, Former Ass. Dir. & US Medical Advisor, Global Compliance & Risk Management, Shire, Chicago, IL
Seth H. Lundy, JD
Partner, King & Spalding, Washington, DC
Ali Lyons
Director, Ethics and Compliance, Aegerion Pharmaceuticals; Former Operations Lead, Ethics and Compliance, Eli Lilly and Company, Cambridge, MA
Joe Mack, JD
Senior Compliance Counsel, Bayer, Former Assistant United States Attorney and Deputy Chief, Health Care and Government Fraud Unit, US Attorney’s Office, District of New Jersey, New York, NY
Stephanie Macholtz, JD, MBA
Director, Compliance and Ethics, Global Medical Affairs and Business Development, Alexion Pharmaceuticals, Inc.; Former Compliance Officer, Biogen, Boston, MA
Colette G. Matzzie, JD
Partner, Phillips & Cohen LLP, Former Civil Appellate Staff and Trial Attorney, Tobacco Litigation Team, US Department of Justice, Washington, DC
Dennis McCloskey, JD
Compliance Officer, Olympus Corporation of the Americas, Former Assistant District Attorney, Homicide Unit, Philadelphia District Attorney’s Office, Philadelphia, PA
Vickie L. McCormick
Vice President, Janssen U.S. Commercial Health, Care Compliance & CIA Operations, Johnson & Johnson, Former Chief Compliance Officer, St. Jude Medical, Titusville, NJ
Jennifer McGee, JD
Vice President and Chief Compliance Officer, Otsuka America Pharmaceutical, Inc., Rockville, MD
Jean McKiernan, MBA
Director, Pharmaceutical and Life Sciences Advisory Practice, PwC, Chicago, IL
Jason P. Mehta, JD
Partner, Bradley Arant Boult Cummings LLP, Former Assistant United States Attorney, US Attorney’s Office for the Middle District of Florida, US Department of Justice, Tampa, FL
Stephanie J. Meltzer, JD
Vice President and Assistant General Counsel, Innovative Health, Pfizer, Former Assistant United States Attorney, United States Attorney’s Office, District of Columbia, US Department of Justice, Boston, MA
Kathleen Meriwether, JD
Americas Leader – Life Science, Forensic & Integrity Services, EY, Former Assistant United States Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA
Brian Miller, PhD
Dir. Compliance Training and Documentation, Otsuka, Former Senior Mgr, Learning Technologies, AstraZeneca, Former Ass. Dir. Learning Design & Technology, Merck, Princeton, NJ
Vahan Minassian, JD
Director, US Promotional Monitoring Lead, Pfizer, Philadelphia, PA
Gregory S. Moss, JD
Senior Vice President, Deputy General Counsel, Kadmon Corporation, New York, NY
Melissa Murphy, MBA
Senior Compliance Specialist, Office of Ethics & Compliance, Medtronic, Minneapolis, MN
Kamleh J. Nicola, LLB
Partner, Baker & McKenzie LLP, Toronto, Canada
Chrisoula Nikidis
Canadian Head of Compliance and Ethics Solutions, IQVIA; Former Executive Director, Ethics and Compliance, Innovative Medicines Canada, Ottawa, Canada
Katherine Cartwright Norris, MPA
Dir., Berkeley Research Group, Former Sr Dir., Compliance, NSF Health Sciences, Former Dir., Corporate Compliance, Spectranetics, Washington, DC
Susan P. Novak
Director, Corporate Policies Global Compliance, Celgene Corporation; Former Director of Compliance, Sandoz; Summit, NJ
Adam Oakley
Director, Potomac River Partners, Arlington, VA
Laura C. O’Donnell
Vice President and General Counsel, GE Healthcare, Warsaw, IN
Josh T. O’Harra, MS, JD
Assistant General Counsel, Eli Lilly and Company; Former Sr. Associate, King & Spalding, Washington, DC
Agatha O’Malley, MStPH, JD
Privacy Officer and Senior Counsel, Otsuka Pharmaceuticals (US), Former Director – Head of Privacy, Shire, Philadelphia, PA
David W. Opderbeck, JD
Professor of Law, Seton Hall University Law School; Counsel, Gibbons PC, Newark, NJ
Tricia Van Orden
Deputy Director, Trade Promotion Coordinating Committee Secretariat, International Trade Administration, US Department of Commerce, Washington, DC
John Patrick Oroho, JD
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ
Amy Pawloski
Compliance Officer – Operations at Endo Pharmaceuticals, Former Global Lead, Compliance Risk Mitigation and Monitoring Strategy, Bristol-Myers Squibb; Philadelphia, PA
Joe Philipose, JD
Vice President, US & Enterprise Compliance, Alexion, Former Director of Compliance, Salix, Former Director, PwC Life Sciences Consulting, Boston, MA
Roy Pollitt
Managing Director, Americas Head, Investigations, Exiger, Former Special Agent, Federal Bureau of Investigation, New York, NY
Perri Pomper, JD
Former Director – Ethics and Compliance Strategy & Education, Novo Nordisk, New York, NY
John Seungjoo Rah, JD
Partner at DLA Piper, Washington, DC
Kelly N. “Nikki” Reeves, MPA, JD
Partner, King & Spalding LLP, Washington, DC
John C. Richter
Partner, King & Spalding, Washington, DC
Margaret Erin Rodgers-Schmidt, JD
Partner, Morgan Lewis & Bockius, Philadelphia, PA
Jeffrey Rosenbaum, MBA
Partner and Co-founder, Dovetail Consulting Group, LLC, Former SVP, Chief Compliance and Risk Officer, Shire, Boston, MA
David Ryan, JD
Vice President and Chief Compliance Officer, Epizyme, Former Vice President, Associate GC and CCO, Haemonetics, Boston, MA
Mark Scallon, MHA
Senior Principal, Polaris, IQVIA Global Compliance, Richmond, VA
Philip Lo Scalzo, JD
Senior Vice President, Chief Compliance Officer, BioMarin; Former Assistant General Counsel, sanofi-aventis, Novato, CA
Cheryl J. Scarboro, JD
Partner, Simpson Thacher & Bartlett, Former, Chief, FCPA Unit, Enforcement Division, US SEC, Washington, DC
Angela Schwartz, JD
Senior Manager, Fraud Investigations & Dispute Services, Life Sciences, EY, Philadelphia, PA
Sue Seferian, JD
Health Care Compliance Officer, Johnson & Johnson, Titusville, NJ
George Serafin, MS
National Health Care and Life Sciences Leader, Grant Thornton, LLP, Iselin, NJ
Nicole Serena
Director, PSP Consulting Services, MATRIX Healthcare Strategists Inc.; Former Director, Patient Access, Bayer; Canada
Patterson Shafer
Managing Director, Health Care and Life Sciences, Grant Thornton, Stamford, CT
Michael Shaw, JD
Vice President and Compliance Officer, US Pharmaceuticals, GlaxoSmithKline, Former Senior Counsel, Office of Inspector General, US DHHS, Former PCF Co-chair, Philadelphia, PA
Laura (Munns) Skinner, MBA
Senior Manager, Life Sciences Advisory, Deloitte, Austin, TX
Jon Smollen, MA, JD
Practice Professor of Law and Director, Center for Compliance and Ethics, Temple Law, Former EVP and CCO, Endo International, Philadelphia, PA
Eugene F. Soltes, MBA, PhD
Jakurski Family Associate Professor of Business Administration, Harvard Business School, Author, Why They Do It: Inside the Mind of the White-Collar Criminal, Cambridge, MA
Oliver Steck
Principal, Life Sciences Regulatory and Operational Risk, Deloitte & Touche LLP, New York, NY
Tim Stow, JD
Senior Vice President and Head of Legal International, Shire, Former VP, Head of Legal Europe, International & Asia Pacific, UCB, Boston, MA
Silvija A. Strikis, JD
Partner, Kellogg Hansen Todd, Figel & Frederick, Former Law Clerk, Justice Sandra Day O’Connor, US Supreme Court, Washington, DC
Ravi Tayi, MD, MPH
Chief Medical Officer, US Ferring Pharmaceuticals; Former Vice President, Global Medical Affairs, Mallinckrodt; Former Vice President, Medical Affairs and Clinical Development, Cubist/Optimer, New York, NY
Ann-Marie Tejcek, MA
Senior Director, Ethics & Compliance, Eli Lilly and Company, Indianapolis, IN
Bryan Timer, MA Business Analytics
Director, Data Analytics & Transparency, Merck, North Wales, PA
Nancy Schwalje Travis, MIA
Vice President, International Compliance and Governance, AdvaMed, Former Deputy Director, Office of Economic Policy, Asia-Pacific Bureau, US Department of State, Washington, DC
Brian Van Hoy
Vice President, G&M Health LLC, Former Director, Ethics and Compliance, Eli Lilly, Bridgewater, NJ
Jennifer Vondee, MPH
Manager, Pharmaceutical & Life Sciences Risk Consulting, PwC, Durham, NC
Julie Ritchie Wagner, JD
Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS; Washington, DC
Lisa Walkush, EMTM
Partner, Grant Thornton, LLP, Philadelphia, PA
William Weinreb, JD
Partner, Quinn Emanuel, Former Acting United States Attorney and First Assistant US Attorney, Boston, Boston, MA
Sarah Whipple, JD
Senior Corporate and Compliance Counsel, Akebia Therapeutics, Inc., Former VP, Global Compliance & Privacy Officer, Aegerion, Former CCO and Assoc. GC, AMAG, Boston, MA
Donna White
Vice President, Contracts & Compliance, Chiesi USA, Inc., Former Sr. Director, Contracts and Compliance, Cornerstone Therapeutics, Cary, NC
Seth B. Whitelaw, JD, LLM, SJD
President and Chief Executive Officer, Whitelaw Compliance Group, LLC, Editor, Life Science Compliance Update, West Chester, PA
Jonathan Wilkenfeld, MBA
Partner, Potomac River Partners, Washington, DC
Russell Williams
Vice President, Government Relations and Public Affairs, Diabetes Canada, Patient Co-Chair, APEC Biopharmaceutical Working Group, Former President, Innovative Medicines Canada – Médicaments novateurs Canada, Ottawa, Canada
Kathryn “Katie” E. Winson
Senior Manager, US HCC Monitoring, Celgene Corporation, Summit, NJ
2018-2019 GLOBAL PHARMA COMPLIANCE CONGRESSES
NINETEENTH ANNUAL PHARMACEUTICAL AND
MEDICAL DEVICE COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum (PCF)
November 7 – 9, 2018
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
THIRTEENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partners: Life Sciences Compliance Update
April 8 – 10, 2019
Grand Hyatt Athens
Athens, Greece
www.InternationalPharmaCongress.com
NINTH ASIA PACIFIC PHARMACEUTICAL AND
MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS)
Media Partners: Life Sciences Compliance Update
September, 2019
Shanghai, China
www.AsianPharmaCongress.com